Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Journal of Medical Imaging and Radiation Oncology|March 2, 2022
Part 2: Imaging findings of uncommon but important immune checkpoint inhibitor-related adverse effectsGeertje Noë, Anthony Cardin, Arian LasockiJournal of Medical Imaging and Radiation Oncology|March 4, 2022
Part 1: Imaging findings of common immune checkpoint inhibitor-related adverse effectsGeertje Noë, Anthony Cardin, Arian LasockiThe American Journal of Hospice & Palliative Care|March 24, 2016
Examining Clinical Utility of Imaging for Inpatient Palliative CareMatthew Paul Grant, Anthony Cardin, Niamh O'Connor, et al.Cancer Imaging : the Official Publication of the International Cancer Imaging Society|March 19, 2024
Assessment of perineural spread in advanced cutaneous squamous cell carcinomas treated with immunotherapyKarda Cavanagh, Luke S McLean, Annette M Lim, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 5, 2024
Evaluating the Utility of <sup>18</sup>F-FDG PET/CT in Cancer of Unknown PrimaryTharani Sivakumaran, Anthony Cardin, Jason Callahan, et al.Cancer Imaging : the Official Publication of the International Cancer Imaging Society|October 14, 2021
FDG-PET/CT imaging for evaluating durable responses to immune check point inhibitors in patients with advanced cutaneous squamous cell carcinomaLuke S McLean, Karda Cavanagh, Rodney J Hicks, et al.Oral Oncology|October 24, 2022
The negative predictive value of FDG PET/CT staging in early oropharyngeal squamous cell carcinoma and implications to transoral robotic surgery patient selectionMario Tapia, Jamil Manji, Kaman Dhillon, et al.European Journal of Nuclear Medicine and Molecular Imaging|March 26, 2025
Safety and efficacy of re-treatment with [<sup>177</sup>Lu]Lu-DOTA-Octreotate radionuclide therapy in progressive gastro-entero-pancreatic neuroendocrine tumours - a single centre experienceRaghava Kashyap, Ramin Alipour, Emma Boehm, et al.Frontiers in Medicine|December 5, 2022
AlphaBet: Combination of Radium-223 and [<sup>17</sup> <sup>7</sup>Lu]Lu-PSMA-I&T in men with metastatic castration-resistant prostate cancer (clinical trial protocol)Louise Kostos, James P Buteau, Theresa Yeung, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 25, 2026
Prognostic Value of Restaging [<sup>18</sup>F]FDG PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer Undergoing [<sup>177</sup>Lu]Lu-PSMA-617 TherapyRaghava Kashyap, James P Buteau, Nathan Papa, et al.Pageof 2